Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Unknown 4Completed 3Not yet recruiting 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 3

Sponsor

Cancer Type

Thoracic 4

Conditions

Carcinoma, Non-Small-Cell Lung 3Adenocarcinoma of Lung 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 284Drug Therapy 244apatinib 242Bevacizumab 230camrelizumab 214Etoposide 200Irinotecan 177Doxorubicin 175Leucovorin 162Dexamethasone 160sintilimab 142pembrolizumab 140anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Interventional × Angiogenesis Inhibitors × Clear all
NCT04459078 2022-12-02

Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma

Hunan Cancer Hospital

Phase 2 Unknown
63 enrolled
Thoracic

Adenocarcinoma of Lung

NCT05507606 2022-08-19

Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown
50 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05273814 2022-07-13

Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 1 Unknown
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03461185 2018-03-09

Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer

Xinqiao Hospital of Chongqing

Phase 2 Unknown
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡